Search Results - "RABENSTEIN, Carola"

Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse by PACHMANN, Katharina, CAMARA, Oumar, RABENSTEIN, Carola, PACHMANN, Ulrich, RUNNEBAUM, Ingo, HÖFFKEN, Klaus, KAVALLARIS, Andreas, KRAUSPE, Sabine, MALARSKI, Nele, GAJDA, Mieczyslaw, KROLL, Torsten, JÖRKE, Cornelia, HAMMER, Ulrike, ALTENDORF-HOFMANN, Annelore

“…To demonstrate that it is possible to monitor the response to adjuvant therapy by repeated analysis of circulating epithelial tumor cells (CETCs) and to detect…”
Get full text

Circulating tumor cells during and beyond maintenance therapy with SERM or aromatase inhibitors for decision making in long-term survivorship by Pachmann, Katharina, Rabenstein, Carola, Camara, Oumar, Rengsberger, Matthias, Runnebaum, Ingo B., Pachmann, Ulrich A.

“…Abstract only 119 Background: Although current guidelines still support 5 years of hormone blocking therapy after primary breast cancer due to earlier results…”
Get full text

Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy by Pachmann, Katharina, Camara, Oumar, Kohlhase, Annika, Rabenstein, Carola, Kroll, Torsten, Runnebaum, Ingo B., Hoeffken, Klaus

“…Purpose In malignant tumors, predictive markers have been developed with respect to targeted therapies. One of the first targeted therapies was the…”
Get full text

Epithelial Cell Dissemination and Readhesion : Analysis of Factors Contributing to Metastasis Formation in Breast Cancer by Hekimian, Katya, Meisezahl, Sandra, Trompelt, Kristin, Rabenstein, Carola, Pachmann, Katharina

“…Although considerable progress has been achieved in breast cancer diagnosis and treatment, the live-saving effect of mammography has hardly been measurable and…”
Get full text

Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment by Camara, Oumar, Jörke, Cornelia, Hammer, Ulrike, Egbe, Anne, Rabenstein, Carola, Runnebaum, Ingo B, Hoeffken, Klaus, Pachmann, Katharina

“…Background In breast cancers, the gene for the growth factor receptor HER2 can be amplified leading to increased aggressiveness and metastasis formation. The…”
Get full text